SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-24-001001
Filing Date
2024-06-21
Accepted
2024-06-21 16:03:47
Documents
16
Period of Report
2024-06-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e5764_8k.htm   iXBRL 8-K 35051
2 EXHIBIT 4.1 e5764_ex4-1.htm EX-4.1 60318
3 EXHIBIT 10.1 e5764_ex10-1.htm EX-10.1 108904
4 EXHIBIT 99.1 e5764_ex99-1.htm EX-99.1 4803
  Complete submission text file 0001731122-24-001001.txt   427316

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE renb-20240614.xsd EX-101.SCH 3024
6 XBRL LABEL FILE renb-20240614_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE renb-20240614_pre.xml EX-101.PRE 22365
19 EXTRACTED XBRL INSTANCE DOCUMENT e5764_8k_htm.xml XML 3683
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO INC. (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 241060110
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)